LicianPro

Andrea Newkirk

Equity research analyst · Goldman Sachs

Earnings calls

1

Nov 2, 2026 – Nov 2, 2026

Stocks asked about

1

Questions

1

Firm rating actions

0

on these stocks, from news

Coverage

Companies whose earnings calls Andrea Newkirk asked questions on (from Lician's transcripts).

Questions on earnings calls

    • 45:51
      “Asuma, maybe here to follow up on NK, could you just remind us on the inclusion criteria with respect to... to the expected proportion of Oxervate experienced versus naive patients? And then also just given the availability of commercial Oxervate, especially in the U.S., would…”

Quotes are machine transcriptions of the official webcast (Whisper) and may contain errors; the timestamp opens the call at that moment.

Goldman Sachs rating actions on these stocks

From news headlines Lician stores, each linked to its source. A headline names the firm; it may not name Andrea Newkirk. We do not use licensed rating databases.

No rating action by Goldman Sachs on these stocks in the headlines we store yet.